PL2504350T3 - Sposób oczyszczania glikoprotein - Google Patents

Sposób oczyszczania glikoprotein

Info

Publication number
PL2504350T3
PL2504350T3 PL10788242T PL10788242T PL2504350T3 PL 2504350 T3 PL2504350 T3 PL 2504350T3 PL 10788242 T PL10788242 T PL 10788242T PL 10788242 T PL10788242 T PL 10788242T PL 2504350 T3 PL2504350 T3 PL 2504350T3
Authority
PL
Poland
Prior art keywords
glycoproteins
purification
Prior art date
Application number
PL10788242T
Other languages
English (en)
Inventor
Steffen Goletz
Lars Stöckl
Original Assignee
Glycotope Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42173838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2504350(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glycotope Gmbh filed Critical Glycotope Gmbh
Publication of PL2504350T3 publication Critical patent/PL2504350T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL10788242T 2009-11-24 2010-11-24 Sposób oczyszczania glikoprotein PL2504350T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26393109P 2009-11-24 2009-11-24
EP09014585A EP2325194A1 (en) 2009-11-24 2009-11-24 Process for the purification of glycoproteins
EP10788242.5A EP2504350B1 (en) 2009-11-24 2010-11-24 Process for the purification of glycoproteins

Publications (1)

Publication Number Publication Date
PL2504350T3 true PL2504350T3 (pl) 2017-08-31

Family

ID=42173838

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10788242T PL2504350T3 (pl) 2009-11-24 2010-11-24 Sposób oczyszczania glikoprotein

Country Status (12)

Country Link
US (1) US8846344B2 (pl)
EP (2) EP2325194A1 (pl)
JP (1) JP5840135B2 (pl)
KR (1) KR101860830B1 (pl)
CN (1) CN102656182B (pl)
AU (1) AU2010324104C1 (pl)
CA (1) CA2781132A1 (pl)
DK (1) DK2504350T3 (pl)
ES (1) ES2626248T3 (pl)
LT (1) LT2504350T (pl)
PL (1) PL2504350T3 (pl)
WO (1) WO2011063943A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7470672B2 (en) 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
EP2968391A1 (en) 2013-03-13 2016-01-20 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种促性腺激素的纯度测定方法
MX2016013416A (es) * 2014-04-18 2017-01-18 Cadila Healthcare Ltd Nuevo proceso de purificacion de gonadotropina.
CA2945883A1 (en) 2014-04-18 2015-10-22 Glycotope Gmbh Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone
US9920107B2 (en) * 2014-05-23 2018-03-20 Instituto Massone S.A. Process for obtaining HMG-UP (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants
US20180264086A1 (en) 2015-09-17 2018-09-20 Glycotope Gmbh Mammalian follicle-stimulating hormone composition with increased stability
PL3436051T3 (pl) * 2016-03-31 2022-02-07 Spark Therapeutics, Inc. W pełni skalowalny sposób kolumnowego wytwarzania raav
CN106008662A (zh) * 2016-05-16 2016-10-12 南京农业大学 一种以枸杞蜂花粉为原料制备富锌中性糖蛋白的方法
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN106732464B (zh) * 2017-02-02 2020-11-20 复旦大学 一种亲水树枝和c18修饰的磁性石墨烯材料及其制备方法和应用
US11385238B2 (en) * 2017-06-30 2022-07-12 Amgen Inc. Methods of protein clips recovery
CN110563832B (zh) * 2019-07-31 2025-11-14 江苏璟泽生物医药有限公司 一种高纯度重组促卵泡刺激素纯化方法
EP4073083A1 (en) * 2019-12-12 2022-10-19 EMD Millipore Corporation Intensified virus filtration using diafiltration buffer
EP3964523A1 (en) * 2020-09-04 2022-03-09 PreviPharma Consulting GmbH Preparation of fetuin a by hydrophobic interaction chromatography
WO2022068898A1 (zh) * 2020-09-29 2022-04-07 迈威(上海)生物科技股份有限公司 一种双取代桥连抗体偶联药物的制备方法
CN114835796A (zh) * 2022-05-05 2022-08-02 江苏尤里卡生物科技有限公司 一种促性腺激素纯化方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US4840896A (en) 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
DE3777623D1 (de) * 1986-12-07 1992-04-23 Morinaga Milk Industry Co Ltd Kolonie-stimulierender faktor und verfahren zu seiner herstellung.
IT1206302B (it) 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
KR0176693B1 (ko) 1989-12-22 1999-04-01 레지널드 디. 쇼트보그; 제롬 반 쥘렌 조절요소를 사용한 내인성 유전자의 발현을 변형시키는 방법
JP3330373B2 (ja) 1990-05-08 2002-09-30 ユニバーシティー オブ メディスン アンド デンティストリー オブ ニュー ジャージー 変容免疫学的特性、性能および／またはレセプター特異性を有する糖タンパク質ホルモンの類似体
WO1992022568A1 (en) 1991-06-18 1992-12-23 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
IL117849A (en) 1995-04-14 2002-07-25 Lepetit Spa Chromatographic process for clearing glycoproteins
UA60311C2 (uk) * 1996-10-02 2003-10-15 Смітклайн Бічам Корпорейшн Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
IT1287138B1 (it) 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
IL122732A0 (en) 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
ATE335000T1 (de) 1997-06-25 2006-08-15 Applied Research Systems Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
US6414123B1 (en) 1997-10-21 2002-07-02 Vitro Diagnostics, Inc. Method for purifying FSH
HUP0101961A3 (en) 1998-05-07 2003-08-28 Transkaryotic Therapies Inc Ca Modifying the expression of the fsh beta gene by homologous recombination
CA2335340C (en) 1998-07-23 2013-03-05 Eli Lilly And Company Fsh and fsh variant formulations, products and methods
ATE358139T1 (de) 1999-04-16 2007-04-15 Inst Massone S A Verfahren zur herstelllung von gonadotropin- zusammensetzungen
WO2001058493A1 (en) 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
SE0001660D0 (sv) 2000-05-05 2000-05-05 Gramineer Ab Separation of glyco-containing entities
EP1610822B2 (en) 2003-04-02 2018-09-19 Ares Trading S.A. Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
US7754860B2 (en) * 2003-12-22 2010-07-13 Ares Trading S.A. Method for purifying FSH
CA2553257A1 (en) * 2004-01-14 2005-08-04 Ohio University Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
EP1751177A4 (en) * 2004-04-19 2008-07-16 Univ Ohio CROSSLINKABLE GLYCOPROTEINS AND METHODS OF MAKING THE SAME
KR101173717B1 (ko) 2004-11-09 2012-08-13 아레스 트레이딩 에스.에이. Ｆｓｈ를 정제하는 방법
CA2625978A1 (en) 2005-12-09 2007-06-14 Ares Trading S.A. Method for purifying fsh or a fsh mutant
ES2391657T3 (es) 2006-02-07 2012-11-28 Shire Human Genetic Therapies, Inc. Composiciones estabilizadas de proteínas que tienen un resto tiol libre
EA022993B1 (ru) 2007-06-28 2016-04-29 Рациофарм Гмбх Молекулы нуклеиновой кислоты, кодирующие альфа- и бета-цепи фолликулостимулирующего гормона человека (fsh)
DE102008002209A1 (de) * 2008-06-04 2009-12-10 Evonik Degussa Gmbh Verfahren zur Aufreinigung von Erythropoietin

Also Published As

Publication number Publication date
LT2504350T (lt) 2017-06-12
JP5840135B2 (ja) 2016-01-06
DK2504350T3 (en) 2017-06-12
KR20120089755A (ko) 2012-08-13
CN102656182B (zh) 2015-03-18
US20120252069A1 (en) 2012-10-04
ES2626248T3 (es) 2017-07-24
KR101860830B1 (ko) 2018-05-24
AU2010324104A1 (en) 2012-06-07
EP2504350A1 (en) 2012-10-03
WO2011063943A1 (en) 2011-06-03
EP2325194A1 (en) 2011-05-25
EP2504350B1 (en) 2017-05-10
CA2781132A1 (en) 2011-06-03
CN102656182A (zh) 2012-09-05
AU2010324104C1 (en) 2015-06-11
AU2010324104B2 (en) 2015-02-19
JP2013511481A (ja) 2013-04-04
US8846344B2 (en) 2014-09-30

Similar Documents

Publication Publication Date Title
PL2504350T3 (pl) Sposób oczyszczania glikoprotein
ZA201202504B (en) Process for the preparation of calcobutrol
PL2425721T3 (pl) Sposób oczyszczania wysokiej czystości mogrozydów
IL261526A (en) Methods for the purification of deoxycholic acid
PT2913337T (pt) Processo para a produção de sofosbuvir
ZA201200409B (en) Compounds for the reduction of b-amyloid production
ZA201202523B (en) Method for the purification of adenovirus particles
GB0922623D0 (en) Methods for the purification of cucurbituril
ZA201104848B (en) Process for purifying lipopeptides
IL243248A0 (en) Purification method
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
IL216942A0 (en) Process for the manufacture of alkenones
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
ZA201105709B (en) Process for the synthesis of cleistanthin
ZA201300320B (en) Purification process
EP2516412A4 (en) PROCESS FOR CLEANING LUBIPROSTON
IL217139A0 (en) Process for the preparation of arylpyridinyl compounds
PL2391633T3 (pl) Sposób odzyskiwania beta-acetylofuranozydu
HUE11718776T2 (hu) Ipari eljárás (S)-(+)-pregabalin elõállítására
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
ZA201201657B (en) Processes for the preparation of vardenafil
GB0905895D0 (en) Process for the preparation of chalcogenone compounds
IL220160A (en) A process for the preparation of defrasirox
PL389568A1 (pl) Sposób otrzymywania 2-metyloglicydolu
PL388929A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych alkoksysilanów